📰 Bio Raises News
Bio Raises News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Bio Raises. Real-time updates on events, politics, business and more.
February 27, 2024
Dublin, Feb. 27, 2024 (GLOBE NEWSWIRE) -- The
February 27, 2024
/PRNewswire/ -- The "Respiratory Infection Diagnostic Markets by Technology, Plex, Place, Product and by Region With Executive and Consultant Guides 2024-2028"...
September 20, 2023
San Diego-based pharmaceuticals company RayzeBio said on Tuesday that it has closed on its $358M IPO, selling 19,869,240 shares of its common stock at $18.00 per share. The IPO also saw an full exercise o
January 31, 2023
/PRNewswire/ -- The "Respiratory Infection Diagnostic Markets by Technology, Plex, Place, Product and by Region with Executive and Consultant Guides" report...
February 9, 2022
/PRNewswire/ -- The "Respiratory Infection Diagnostic Markets by Technology, Plex, Place, Product and by Region With Covid-19 Impact & Forecasting/Analysis,...
October 6, 2021
Dublin, Oct. 06, 2021 (GLOBE NEWSWIRE) -- The "Respiratory Infection Diagnostic Markets by Technology, Plex, Place, Product and by Region With Covid-19...
October 6, 2021
/PRNewswire/ -- The "Respiratory Infection Diagnostic Markets by Technology, Plex, Place, Product and by Region With Covid-19 Impact & Forecasting/Analysis,...
October 6, 2021
/PRNewswire/ -- The "Respiratory Infection Diagnostic Markets by Technology, Plex, Place, Product and by Region With Covid-19 Impact & Forecasting/Analysis,...
May 5, 2021
Published: May 05, 2021 By Mark Terry There’s money on the move and venture capital firms launch several biotech companies with hefty Series A financing rounds. Here’s a look. Esker Launches with $70 Million Series A San Francisco-based Esker Therapeutics, a Foresite Labs-incubated company, launched with a $70 million Series A financing. The round was led by Foresite Capital. The company focuses on autoimmune diseases and so-called precision therapies that target patients most lik...